Related Experiment Video
Updated: Dec 26, 2025

Whole Vitreous Humor Dissection for Vitreodynamic Analysis
Published on: May 24, 2015
Vitreous and Vision Degrading Myodesopsia.
1VMR Institute for Vitreous Macula Retina, Huntington Beach, CA, USA; Doheny Eye Institute, Pasadena, CA, USA; Department of Ophthalmology, Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Vitreous floaters, often caused by myopia and aging, can significantly impair vision and quality of life. Vision Degrading Myodesopsia requires improved diagnostics and therapies beyond current options like vitrectomy.
Area of Science:
- Ophthalmology
- Biochemistry
- Medical Diagnostics
Background:
- Macromolecules are crucial for vitreous humor's gel state, transparency, and function.
- Myopia and aging disrupt collagen and hyaluronan, leading to vitreous liquefaction and degeneration.
- Vitreous opacities and posterior vitreous detachment cause floaters, impacting vision and quality of life.
Purpose of the Study:
- To highlight the impact of vitreous opacities on vision.
- To introduce Vision Degrading Myodesopsia as a diagnosable condition.
- To advocate for improved diagnostics and therapies for severe cases.
Main Methods:
- Echographic assessment of vitreous structure.
- Measurement of contrast sensitivity function.
- Review of current and potential therapeutic strategies.
Main Results:
- Vitreous opacities can profoundly degrade contrast sensitivity.
- Vision Degrading Myodesopsia is identifiable through specific diagnostic measures.
- Vitrectomy is the definitive treatment, while YAG laser has limited efficacy.
Conclusions:
- Existing treatments for Vision Degrading Myodesopsia are limited.
- Further research into diagnostics and therapies, including laser, pharmacotherapy, and optical corrections, is needed.
- Understanding pathogenesis may lead to prevention strategies.
More Related Videos
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
07:12Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
Published on: April 11, 2025
Related Concept Videos
Photoreceptors and Visual Pathways
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Focusing of Light in the Eye
Anatomy of the Eyeball